Future Lipid-Altering Therapeutic Options Targeting Residual Cardiovascular Risk
Crossref DOI link: https://doi.org/10.1007/s11886-016-0743-8
Published Online: 2016-05-23
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Farnier, Michel
Text and Data Mining valid from 2016-05-23